Mesterolone: Historical Perspectives, Clinical Applications, and Emerging Experimental Evidence

Abstract

Mesterolone (1-alpha-Methyl-5-alpha-androstan-17-beta-ol-3-one) is a synthetic orally active dihydrotestosterone derivative introduced during the 1960s as a comparatively mild androgen with limited antigonadotropic and hepatotoxic effects relative to many contemporary oral anabolic steroids. This paper summarizes the historical development, pharmacological characteristics, clinical applications, and experimental studies related to mesterolone over more than five decades.

Early experimental and clinical investigations demonstrated that mesterolone exerted androgenic activity while producing relatively limited suppression of luteinizing hormone, follicle-stimulating hormone, spermatogenesis, and endogenous testicular function. Unlike many 17α-alkylated oral androgens, mesterolone was generally associated with a lower incidence of clinically significant hepatotoxicity. These characteristics led to its investigation in a variety of clinical conditions including male hypogonadism, impotence, aging male syndrome, idiopathic oligospermia, renal anemia in chronic hemodialysis patients, depressive symptoms, nocturnal enuresis, and certain hepatic disorders.

The most consistent clinical evidence supports its use in mild to moderate male infertility associated with oligospermia, where several studies demonstrated improvements in sperm concentration, seminal parameters, and pregnancy rates. Additional studies reported beneficial effects on libido, erectile function, psychosomatic symptoms, and quality of life in androgen-deficient males. Long term studies in renal anemia suggested improvement in hemoglobin levels and reduced transfusion requirements with relatively favorable tolerability.

More recent experimental research demonstrated that mesterolone influences skeletal muscle hypertrophy, satellite-cell activation, nitric oxide signaling, mitochondrial adaptation, tendon remodeling, and connective tissue structure. These findings suggest possible future applications in sarcopenia, rehabilitation medicine, and muscle-wasting disorders, although current evidence remains largely preclinical.

Despite its historically favorable safety reputation, modern studies indicate that mesterolone may adversely affect lipid metabolism and, in rare cases, may induce liver injury. Therefore, careful long term monitoring remains important during therapy.

Overall, mesterolone represents a distinctive oral androgen with unique pharmacological properties and a broad historical range of therapeutic applications. However, most available evidence predates modern standards of randomized clinical investigation, and contemporary controlled studies are required to better define its efficacy, safety, and optimal clinical role.

Keywords: Mesterolone; Safety; Therapeutic Applications

Citation

Aamir Jalal Al-Mosawi. Mesterolone: Historical Perspectives, Clinical Applications, and Emerging Experimental Evidence. WebLog J Pharmacol Ther. wjpt.2026.j0802. https://doi.org/10.5281/zenodo.23312379